SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-032518
Filing Date
2017-05-15
Accepted
2017-05-15 07:00:59
Documents
5
Period of Report
2017-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-13100_18k.htm 8-K 34540
2 EX-10.1 a17-13100_1ex10d1.htm EX-10.1 20623
3 EX-99.1 a17-13100_1ex99d1.htm EX-99.1 10267
4 GRAPHIC g131001mmi001.jpg GRAPHIC 4531
5 GRAPHIC g131001kki001.jpg GRAPHIC 8855
  Complete submission text file 0001104659-17-032518.txt   85529
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 17840998
SIC: 2834 Pharmaceutical Preparations